These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30151086)

  • 1. Synthesis and pre-clinical evaluation of a potential radiotracer for PET imaging of the dopamine D
    Stewart MN; Shao X; Desmond TJ; Forrest TJ; Arteaga J; Stauff J; Scott PJH
    Medchemcomm; 2018 Aug; 9(8):1315-1322. PubMed ID: 30151086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntheses and in vitro evaluation of fluorinated naphthoxazines as dopamine D2/D3 receptor agonists: radiosynthesis, ex vivo biodistribution and autoradiography of [(18)F]F-PHNO.
    Vasdev N; Seeman P; Garcia A; Stableford WT; Nobrega JN; Houle S; Wilson AA
    Nucl Med Biol; 2007 Feb; 34(2):195-203. PubMed ID: 17307127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11C-Fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain.
    Mukherjee J; Shi B; Christian BT; Chattopadhyay S; Narayanan TK
    Bioorg Med Chem; 2004 Jan; 12(1):95-102. PubMed ID: 14697774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography.
    Wilson AA; McCormick P; Kapur S; Willeit M; Garcia A; Hussey D; Houle S; Seeman P; Ginovart N
    J Med Chem; 2005 Jun; 48(12):4153-60. PubMed ID: 15943487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of probes for PET imaging of dopamine D3 receptors.
    Doot RK; Dubroff JG; Labban KJ; Mach RH
    Neurosci Lett; 2019 Jan; 691():18-25. PubMed ID: 29518538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents.
    Mukherjee J; Majji D; Kaur J; Constantinescu CC; Narayanan TK; Shi B; Nour MT; Pan ML
    Synapse; 2017 Mar; 71(3):. PubMed ID: 27864853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies.
    Mach RH; Luedtke RR
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):291-298. PubMed ID: 28857231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors.
    Yang ZY; Perry B; Mukherjee J
    Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosynthesis and Preliminary Evaluation of [
    Li KP; Gleba JJ; Parent EE; Knight JA; Copland JA; Cai H
    Mol Pharm; 2023 Aug; 20(8):4129-4137. PubMed ID: 37409698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ¹²⁴I-Epidepride: a PET radiotracer for extended imaging of dopamine D2/D3 receptors.
    Pandey S; Venugopal A; Kant R; Coleman R; Mukherjee J
    Nucl Med Biol; 2014; 41(5):426-31. PubMed ID: 24602412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
    Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
    J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separating dopamine D
    Smart K; Gallezot JD; Nabulsi N; Labaree D; Zheng MQ; Huang Y; Carson RE; Hillmer AT; Worhunsky PD
    Neuroimage; 2020 Jul; 214():116762. PubMed ID: 32201327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro and in vivo evaluation of
    Narayanaswami V; Tong J; Fiorino F; Severino B; Sparaco R; Magli E; Giordano F; Bloomfield PM; Prabhakaran J; Mann JJ; Vasdev N; Dahl K; Kumar JSD
    EJNMMI Radiopharm Chem; 2020 May; 5(1):13. PubMed ID: 32430632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation in rats of the dopamine D2/3 receptor agonist 18F-AMC20 as a potential radioligand for PET.
    Shalgunov V; van Wieringen JP; Janssen HM; Fransen PM; Dierckx RA; Michel MC; Booij J; Elsinga PH
    J Nucl Med; 2015 Jan; 56(1):133-9. PubMed ID: 25476538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [
    Slifstein M; Abi-Dargham A; Girgis RR; Suckow RF; Cooper TB; Divgi CR; Sokoloff P; Leriche L; Carberry P; Oya S; Joseph SK; Guiraud M; Montagne A; Brunner V; Gaudoux F; Tonner F
    Psychopharmacology (Berl); 2020 Feb; 237(2):519-527. PubMed ID: 31773210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.
    Hicks JW; Parkes J; Sadovski O; Tong J; Houle S; Vasdev N; Wilson AA
    Nucl Med Biol; 2013 Aug; 40(6):740-6. PubMed ID: 23731552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11C-labeling of n-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors.
    Turolla EA; Matarrese M; Belloli S; Moresco RM; Simonelli P; Todde S; Fazio F; Magni F; Kienle MG; Leopoldo M; Berardi F; Colabufo NA; Lacivita E; Perrone R
    J Med Chem; 2005 Nov; 48(22):7018-23. PubMed ID: 16250661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Initial In Vivo Evaluation of [
    Tanzey SS; Shao X; Stauff J; Arteaga J; Sherman P; Scott PJH; Mossine AV
    Pharmaceuticals (Basel); 2018 Dec; 11(4):. PubMed ID: 30551596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
    Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.